Get the Stockscreener App
1.115
2.19%
-0.025
Mangoceuticals Inc stock is traded at $1.115, with a volume of 21,886.
It is down -2.19% in the last 24 hours and down -59.31% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$1.14
Open:
$1.11
24h Volume:
21,886
Relative Volume:
0.02
Market Cap:
$15.85M
Revenue:
$516.00K
Net Income/Loss:
$-14.20M
P/E Ratio:
-0.3496
EPS:
-3.1891
Net Cash Flow:
$-5.83M
1W Performance:
-24.66%
1M Performance:
-59.31%
6M Performance:
-24.66%
1Y Performance:
-55.40%
1-Day Range:
$1.11
$1.115
1-Week Range:
$1.11
$1.39
52-Week Range:
$0.98
$6.15
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.11 | 15.85M | 516.00K | -14.20M | -5.83M | -3.1891 |
|
VEEV
Veeva Systems Inc
|
246.27 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
66.87 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.12 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
48.90 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
34.78 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Mangoceuticals Inc. stock benefit from commodity prices - newser.com
Why Mangoceuticals Inc. stock is favored by pension fundsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Can Mangoceuticals Inc. stock reach $100 price targetWeekly Profit Report & Community Verified Trade Signals - newser.com
Evaluating Mangoceuticals Inc. with trendline analysisJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Why Mangoceuticals Inc. is moving todayJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Is Mangoceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Verified Technical Trade Signals - newser.com
Dir Hamilton Files To Sell 125,000 Of Mangoceuticals Inc [MGRX] - TradingView
How Mangoceuticals Inc. stock performs in weak economyMarket Activity Recap & Weekly Momentum Picks - newser.com
Will Mangoceuticals Inc. benefit from macro trendsStock Surge & Community Consensus Stock Picks - newser.com
Are Direct-to-Consumer Channels Reinforcing Eli Lilly’s (LLY) Competitive Edge in the Obesity Market? - simplywall.st
It is Poised to be a Bull Market for Mangoceuticals Inc (MGRX) - setenews.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Can technical indicators confirm Mangoceuticals Inc.’s reversal2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Can Mangoceuticals Inc. rally from current levelsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Can Mangoceuticals Inc. stock rebound after recent weakness2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs - MSN
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs - MSN
Novo denies partnership with Mangoceuticals on obesity drug, Reuters says - MSN
Can Mangoceuticals Inc. stock sustain free cash flow growth2025 Price Action Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Mangoceuticals Inc. stock supported by strong fundamentalsJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
MANGOCEUTICALS, INC. SEC 10-Q Report - TradingView
Can Mangoceuticals Inc. stock withstand economic slowdown2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Will Mangoceuticals Inc. stock deliver shareholder valueJuly 2025 Snapshot & Entry Point Confirmation Signals - Fundação Cultural do Pará
Mangoceuticals Launches New Weight-Management Programs - MSN
Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim - Yahoo Finance
Visual analytics tools that track Mangoceuticals Inc. performanceMarket Performance Summary & Fast Moving Stock Watchlists - newser.com
Mangoceuticals plunges after denying Lilly, Novo partnerships - Seeking Alpha
Mangoceuticals Inc Clarifies Launch of GLP-1 Programs - TradingView
[8-K] MANGOCEUTICALS, INC. Reports Material Event | MGRX SEC FilingForm 8-K - Stock Titan
Investors Flee Mangoceuticals Stock (MGRX) after Eli Lilly and Novo Nordisk Deny Partnership - TipRanks
MGRXMangoceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
Novo Nordisk, Eli Lilly Say No Partnership on Weight-loss Drugs with Mangoceuticals - MarketScreener
Novo Nordisk, Eli Lilly deny partnership with Mangoceuticals on weight-loss drugs - WISH-TV
Mangoceuticals launches direct GLP-1 medication access programs By Investing.com - Investing.com Nigeria
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs - Reuters
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.19%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):